Biopool Reports Doubling of 2nd Quarter’s Sales
Biopool International in Ventura reported that second-quarter sales doubled to $4.2 million from $2.1 million in the second quarter of 1996.
Net income for the quarter, which ended June 30, was $350,000 or 4 cents per share, compared to $386,000 or 5 cents per share for the same period in 1996.
“Sales have doubled since our acquisition of our BCA Division in January,” said Michael D. Bick, chairman and chief executive officer. “Now we are taking steps to improve our profitability while further growing sales.”
In the third quarter, Bick said, the company will phase out some transitional expenses related to the BCA acquisition, such as running parallel computer and customer-service systems.
Biopool’s line of more than 150 Food and Drug Administration-approved products is sold to hospitals, blood-bank facilities and clinical and reference laboratories throughout the world.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
